News

This is the first supply of consistent, scalable, human muscle cells, providing transformative new models for drug discovery.

The book celebrates leadership and innovation and covers bit.bio's ambition to engineer the future of medicine. 

Short film showcases innovative cell reprogramming technology at event.

Founder and CEO Mark Kotter talks to Eva (The Naked Scientist podcast) about all things cell reprogramming.

Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.

This piece covers what's different about our cell coding approach.

MP Anthony Browne visits bit.bio's labs and offices to officially open facilities.

Episode 3 of our special three part mini-series.